Csenge Advisory Group Adma Biologics, Inc. Transaction History

Csenge Advisory Group

  • $1.97 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020
SELL
$2.04 - $3.74 $30,600 - $56,100
-15,000 Closed
0 $0
Q4 2019

Feb 05, 2020
SELL
$3.89 - $5.15 $31,120 - $41,200
-8,000 Reduced 34.78%
15,000 $60,000
Q3 2019

Nov 14, 2019
BUY
$3.19 - $5.39 $73,370 - $123,969
23,000 New
23,000 $102,000

Others Institutions Holding ADMA

# of Institutions
319
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.48B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email